US obtains Iranian enriched uranium by May 31?

YES price

20¢

per share

NO price

81¢

per share

$166K 24h volume$137K liquidity$2.7M total volumeResolves May 31, 2026

About this market

This market will resolve to “Yes” if the US government or military officially announces or confirms that it has gained possession of any quantity of enriched uranium previously controlled by Iran by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. “Possession” means that the United States has actual physical custody or control of the enriched uranium, whether held within U.S. territory or elsewhere. Announcements of deals, agreements, commitments, or plans under which the United States would acquire possession of Iranian enriched uranium at a later time will not qualify. Qualifying possession of Iranian enriched uranium may be acquired through any means, including through an agreed surrender or seizure. A widespread consensus of credible reporting that the United States has gained possession of Iranian enriched uranium will also qualify for a “Yes” resolution, even if the United States makes no formal announcement. The primary resolution source for this market will be official information from the government of the United States; however, a widespread consensus of credible reporting may also be used.

AI Consensus Analysis

AI consensus is locked

Sign up free to see where Claude, Gemini, and Grok think this market is mispriced.

How Clairvoyant analyzes this market

Three AI agents — Claude (Anthropic), Gemini (Google DeepMind), and Grok (xAI) — independently score this market using real-time web data and historical base rates. Their probability estimates are weighted by a proprietary accuracy model and combined into a consensus probability.

When the consensus diverges from the current market price by more than a minimum threshold, it surfaces as a trade opportunity. Kelly Criterion then sizes the position based on the magnitude of the edge — larger gaps produce larger positions, within hard portfolio caps.

Why 3 agents are better than 1